Immix Biopharma (IMMX) Shares Outstanding (2020 - 2026)

Immix Biopharma has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $53.1 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 90.1% year-over-year to $53.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53.1 million (up 90.1% YoY) and the FY2025 annual result came in at $33.0 million, up 19.39% from the prior year.
• Shares Outstanding (Entity) improved to $53.1 million in Q1 2026 per IMMX's latest filing, from $33.0 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $53.1 million in Q1 2026 and troughed at $13.9 million in Q1 2022.
• A 5-year average of $24.1 million and a median of $26.5 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) soared 313.76% in 2022, then rose 1.17% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $14.0 million in 2022, then jumped by 43.18% to $20.0 million in 2023, then jumped by 38.1% to $27.6 million in 2024, then advanced by 19.39% to $33.0 million in 2025, then soared by 61.03% to $53.1 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $53.1 million, $33.0 million, and $33.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.